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Effective tools are needed to enable prioritization of lead molecules in natural 
products drug discovery research. As the field of mass spectrometry continues to 
advance, more people have access to high-resolution instruments, and more researchers 
rely on this technology for metabolite and compound class identification. To effectively 
access lead molecules from natural product mixtures, it is important to comprehensively 
assess large datasets in the most timely and cost-effective manner. For analyses based on 
liquid chromatography-mass spectrometry (LC-MS), several post-acquisition data 
analysis approaches can be employed to identify analogues of a lead molecule of interest.  
With this study, we sought to compare the effectiveness of mass defect filtering and 
molecular networking for this purpose.  Secondary metabolite production by the ambuic 
acid-producing endophytic fungus Pestalotiopsis microspora was used as a test case for 
these analyses. Eight putative analogues of ambuic acid were identified using mass defect 
filtering and molecular networking analyses. Our results illustrate advantages and 
disadvantages of molecular networking and mass defect filtering and suggest that the 
combination of both data mining techniques may enable the most comprehensive 
evaluation of analogues.
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CHAPTER I 
INTRODUCTION 
 
 
1.1 Antibiotic Resistance 
Over 2 million people are diagnosed with an antibiotic-resistant infections in the 
United States each year, and these infections are responsible for 23,000 annual  
fatalities.1-2  The bacterial pathogens currently considered to be of the highest concern by 
the CDC are known as the ESKAPE pathogens: Enterococcus faecium, Staphylococcus 
aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, 
and Enterobacter species. These pathogens are responsible for many of hospital-acquired 
infections in the United States and are becoming resistant to many, or even all, of the 
antibiotic treatments currently available.1, 3-7  
1.2 Methicillin- Resistant Staphylococcus aureus (MRSA) 
The most prominent and costly skin and soft tissue infections are caused by the 
Gram-positive organism Staphylococcus aureus.8-10 Methicillin-resistant Staphylococcus 
aureus (MRSA) possesses an arsenal of virulence factors that are controlled by a density-
dependent regulatory system known as quorum sensing.11-14 Quorum sensing systems 
allow bacterial cells in close proximity to one another to communicate, activate virulence 
factors contributing to pathogenesis, and more effectively colonize host tissue.11, 15-17  
2 
While over-prescription of antibiotics or lack of antibiotic stewardship2 leads to 
the development of antibiotic resistance in the target organism, targeting and inhibiting 
the pathways that produce these virulence factors is a promising strategy for disarming 
the pathogen. By avoiding the use of antibiotics, this approach could facilitate 
clearance of the infection while lowering the risk of antibiotic resistance development 
and preserving the beneficial microflora.13, 18-21  
1.3 Targeting Anti-virulence for Drug Discovery 
 
MRSA quorum sensing is controlled by the accessory gene regulator (agr) 
system. There are three main protein targets in the agr system for small molecule 
inhibition: AgrC, AgrA, and AgrB. Much research thus far has focused on finding 
inhibitors that target the transmembrane protein AgrC, but this target varies greatly even 
among bacterial strains and has shown evidence of being hypermutable.12, 14, 21-25 The 
AgrB protein of the agr system is a more favorable target because it is highly conserved 
among Gram-positive pathogens.22 To date, the fungal metabolite ambuic acid is the only 
reported agr signal biosynthesis inhibitor that functions via AgrB inhibition.26-29 Ambuic 
acid is reliably produced by the Ascomycete fungus belonging to order Xylariales, 
Pestalotiopsis microspora.30-32 Quorum sensing inhibition by ambuic acid was shown in 
vivo to reduce MRSA-induced abscess formation in a mouse model by half with a 5-µg 
dose.26 Given the success of these initial studies, there is interest in identifying additional 
analogues of ambuic acid that might possess higher potency and/or provide insight into 
the mechanism of action for this compound. 
3 
1.4 Data Mining via Mass Defect Filtering and Molecular Networking 
There is often a priority for the isolation of analogues to conduct structural 
activity relationship studies and identify novel chemical entities. To effectively mine 
large mass spectrometry datasets originating from complex fungal mixtures, data 
processing techniques capable of prioritizing lead ions are often used.33-39 Data 
processing techniques such as molecular networking and mass defect filtering represent 
commonly used approaches for dereplicating and prioritizing lead molecules that have 
structural relatedness to the desired compound within large datasets and can easily be 
incorporated into natural products discovery workflows.34, 39-41  These tools are valuable 
for assessing whether target ions are present and can give insight into whether a specific 
organism should be pursued for natural product discovery.  
Mass defect filtering is a simple tool to identify compounds that have similar 
molecular formulae, and as such, are likely to have similar chemical structures. High 
resolution mass spectrometry has the confidence in four decimal places after the nominal 
mass and allows for higher ability to prediction of molecular formula.42-43 This principles 
of isotopic abundance that each element contributes to this exact mass and the mass 
defect. A filter can be placed on the full scan mass spectra data to isolate ions that only 
fall within an user-defined window around the precursor mass. The absolute value of the 
mass defect of an ion reflects the ion’s elemental composition because each element has a 
unique finite mass defect. The mass defect of a given molecule is defined as the deviation 
between its nominal mass and its exact monoisotopic mass. Numerous studies have 
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utilized mass defect filtering to identify molecules likely to be structurally related to a 
target analyte or a core substructure in an entire mass spectrometry dataset.34, 43-46 Mass 
defect filtering has also been utilized for studies involving drug metabolism,42-43 isotope 
labeling experimentation and removal of media or polymer components.47-48  
Another commonly utilized data mining tool, global natural products social 
molecular networking (GNPS), is a natural product and metabolomics crowdsourced 
analysis platform with public reference libraries, public data repositories, and living 
data.41 This platform utilizes mass spectral fragmentation patterns (MS/MS spectra) to 
build networks of related compounds based on the assumption that structurally similar 
molecules will fragment in a similar way. A series of molecular networks are built by 
utilizing the full MS and MS/MS data, and the ions that are structurally related are 
connected in distinct clusters. GNPS also includes a public database that enables sharing 
of MS/MS spectra among the scientific community, enabling the mining of spectral data 
to prioritize samples and screen for chemical moieties of interest.38, 40-41, 49-53  Using this 
database, it is possible to putatively identify known natural product secondary 
metabolites in a given dataset.40, 52  
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CHAPTER II 
IDENTIFICATION UTILIZING DATA MINING TECHNIQUES: MASS DEFECT 
FILTERING AND MOLECULAR NETWORKING 
 
 
2.1 Abstract 
The goal of this research is to compare molecular networking38, 40, 54 and mass 
defect filtering43-44, 55 as ways to screen natural product mixtures for the presence of 
analogues using the ambuic acid producer P. microspora as a case study.  With this 
project, we sought to demonstrate the advantages and disadvantages of both mass defect 
filtering and molecular networking and provide recommendations to researchers utilizing 
these technologies for natural products discovery research.  
 
2.2 Materials and Methods 
 
  
  
Figure 1. The Workflow for Prioritization of Ambuic Acid Analogues from the 
Pestalotiopsis microspora Organic Extract. P. microspora is cultured onto a solid surface 
agar plate, then inoculated into a liquid medium to be cultured for several weeks. Liquid 
culture is then filtered and extracted with chloroform and methanol and further separated 
using liquid-liquid partitioning between water and organic solvents (methanol and 
acetonitrile). The organic extract is subjected to chromatographic separation and  
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high- resolution mass spectrometry profiling. Using data mining techniques on the mass 
spectrometry data can aid the user to target analogues of interest that can subsequently be 
targeted for isolation. 
 
2.2.1 Solid State Fermentation  
P. microspora culture was procured from Dr. Gary Strobel at the University of 
Montana32 and grown on solid state oatmeal media. Oatmeal media (Old fashioned 
Quaker oats) was prepared using 10 g of rolled oats in seven, 250 mL Erlenmeyer flask 
with approximately 17 mL of deionized-H2O, followed by autoclaving at 221°C for 
30 min using methods outlined previously.56 
2.2.2 Extraction of Fungal Cultures  
To each culture, 60 mL of 1:1 chloroform: methanol (CHCl3:CH3OH) were 
added. Solid media cultures were chopped with a spatula to facilitate extraction. The 
cultures were stirred overnight at room temperature and subsequently filtered under 
vacuum. The filtrate was stirred for 1 hr with 90 mL of CHCl3 and 100 mL deionized-
H2O. This mixture was then transferred to a separatory funnel, and the bottom organic 
layer was removed and evaporated in vacuo. The dried organic extract was reconstituted 
with 100 mL 1:1 acetonitrile: methanol and 100 mL hexanes. This biphasic solution was 
stirred for 1 hr and transferred to a separatory funnel. The bottom layer, representing the 
defatted organic extract, was evaporated to dryness in vacuo.35 
  
7 
2.2.3 Data-Dependent UHPLC-PDA-MS/MS Analysis 
Fungal extracts were dissolved in methanol to obtain a final concentration of 0.1 
mg/mL. Chromatographic separation was performed on an Acquity Ultra-High 
Performance Liquid Chromatography (UPLC) system (Waters, Milford, MA) equipped 
with an autosampler kept at 10°C, photodiode array detector (PDA), column manager and  
binary solvent manager, interfaced to a Q-Exactive Plus mass spectrometer (Thermo 
Scientific, Bremen, Germany), using an electrospray ionization (ESI) source operated in 
both negative and positive ion mode. The UHPLC conditions were as follows: Waters 
BEH C18 100 × 2.1 mm column, 1.7 µm; mobile phase, (A) water with 0.1% formic 
acid; (B) acetonitrile with 0.1% formic acid; flow rate, 300 µL min–1; injection volume, 3 
µL; gradient, linear gradient of 15–85% B over 10 min. The optimized ESI parameters 
were as follows: source voltage, 3.5 kV (pos); sheath gas flow rate (N2), 48 units; 
auxiliary gas flow rate, 11 units; spare gas flow rate, 2.0; capillary temperature, 300°C 
(pos), S-Lens RF Level, 55. The data-dependent MS/MS events were performed on the 
three most intense ions detected in full scan MS. The MS/MS isolation window width 
was 2 Da, and the normalized collision energy (NCE) was set to 40 units. In data-
dependent MS/MS experiments, full scans were acquired at a resolution of 35,000 fwhm 
at a range of m/z 100 to 1200) and MS/MS scans at 17,500 fwhm, both with a maximum 
injection time of 50 ms. 
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2.2.4 Molecular Networking  
The .RAW (Thermo) file format of the organic (methanol and acetonitrile) extract 
was transformed into .mzXML text-based format using the MSConvert software, part of 
the ProteoWizard package, data is described by the scan number, precursor m/z and 
MS/MS fragmentation information.57 The converted files were then uploaded to Global 
Natural Products Social molecular networking (GNPS)41 for the creation of a molecular 
network. MS/MS spectra were window filtered by choosing only the top six peaks in the 
±50 mDa window throughout the spectrum. The molecular network clusters together 
nodes using user-defined parameters. The data were clustered with a precursor mass 
tolerance of 100 mDa and an MS/MS fragment ion tolerance of 0.5 Da to create 
consensus spectra.52 A network was then created where edges were filtered to have a 
cosine score above 0.7 and more than five matched fragment peaks.  
2.2.5 Mass Defect Filtering  
LC-MS data were collected in negative and positive mode and individually 
analyzed, aligned, and filtered using MZmine 2.21.2.58 The .RAW (Thermo) mass 
spectral data file for the organic (1:1 acetonitrile: methanol) P. microspora extract was 
imported into MZmine for peak picking. The negative polarity has a higher ionization 
efficiency for the targeted compounds and only masses within the negative peak lists are 
reported in this study. The chromatogram peak detection was constructed for all m/z 
values lasting longer than 0.1 min, the baseline was set to 3 × 106, m/z variation tolerance  
9 
at 0.05, and m/z intensity and variation tolerance at 20%. The adjusted chromatogram 
then underwent a deconvolution algorithm to recognize the individual peaks. Peaks were 
aligned if their masses were within 5 ppm and their retention times were a maximum of 
0.15 min from one another. The resulting data matrix, consisting of m/z, retention time, 
and peak area, was imported into Excel (Microsoft). In search for isolatable analogues 
throughout the chromatogram, this list was filtered for a final time to obtain only m/z 
values that would be in the ±50 mDa mass defect window around the [M-H]-ion for 
ambuic acid (m/z=349.1651, C19H25O6,) so that the defect range being targeted is 0.1151 
to 0.2151. The peak list was sorted by the exact mass, after which these values were 
truncated into nominal mass and the mass defect. The list was then sorted in reference to 
descending mass defect, the ions that fell outside of this range were removed. 
2.3 Results 
 
2.3.1. Analysis of the Pestalotiopsis microspora Fungal Extract 
The organic (1:1 methanol and acetonitrile) extract of P. microspora was profiled 
using mass spectrometry and examined for analogue prioritization using mass defect 
filtering and molecular networking data mining approaches (Figure 1). Ambuic acid was 
confirmed to be present in the P. microspora extract by comparing accurate mass and 
retention time to that of a standard of ambuic acid (AG-CN2-0129-M001, Adipogen 
Corp., San Diego, CA). Ambuic acid eluted at 4.67 minutes and is the ion with the 
highest signal in the P. microspora extract (Figure 2). The MS/MS spectra are also  
10 
compared as a confirmation, putatively identified ambuic acid ion and that of the standard 
also showed a high degree of similarity in mass and relative abundance of fragments 
detected (Figure 2.) MS/MS fragmentation pattern for the associated ambuic acid peak is 
visualized to the right of the peak in the C and D sections of Figure 2 for the ambuic acid 
peak in sections A and B, respectively.   
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Figure 2. Comparison of Base Peak LC-MS Chromatogram and MS/MS Fragmentation 
Pattern for Ambuic Acid Detection. (A) Base peak LC-MS chromatogram of an ambuic 
acid standard analyzed at a concentration of 0.1 mg/mL. (B) Base peak LC-MS 
chromatogram of an extract, the organic (methanol: acetonitrile) layer of Pestalotiopsis 
microspora culture was analyzed at a concentration of 0.1 mg/mL. (C and D) MS/MS 
fragmentation pattern for the ambuic acid peak in the A and B sections, respectively. 
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2.3.2 Mass Defect Filtering Analysis  
The mass defect of a given molecule is defined as the deviation between its 
nominal mass and its exact monoisotopic mass.  For example, the [M-H]– ion of ambuic 
acid has an exact mass of 349.1651, a nominal mass of 349, and a mass defect of 0.1651 
(Table 1). The difference in mass between ambuic acid and an analogue with one 
additional oxygen atom is quite significant (349.1651 versus 365.1600).  However, the 
mass defects for these two structures (0.1651 versus 0.1600) only differ by 0.0051 Da, 
representing the mass defect specific to oxygen. Mass defect filtering identifies ions that 
are within a defined mass defect window around that of the compound of interest based 
on the assumption that compounds with similar chemical formulas (and thus similar mass 
defects) will be structurally similar.  In this way, it is possible to filter a complex LC-MS 
chromatogram or large dataset to identify a series of molecules with similar mass defects 
for the discovery of structurally related components.  
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Table 1. A Simplified Example of Mass Defect Filtering for the Target Analyte Ambuic 
Acid and a Hydroxylated Analogue. The difference between the exact and nominal mass 
is the mass defect. The mass defect will vary depending on the elemental composition of 
the compound.  This example shows an addition of an oxygen that is responsible for the 
0.0051 Da difference between the two mass defects. 
 
  
 
The goal of this study was to assess the ability of mass defect filtering and 
molecular networking to identify analogues of ambuic acid for natural product discovery, 
only ions detected above the baseline of 3 x 106 were considered for analysis. Of the 183 
ions detected above baseline in negative ionization mode (Figure 2), 84 ions had mass 
defects within 50 mDa from that of ambuic acid (mass defect range of 0.1151 to 0.2151).  
2.3.3 Molecular Networking Analysis 
 
A visual explanation of how data is processed for molecular networking is 
represented in Figure 3. The full MS spectrum (A) is utilized to create the final molecular 
Name Structure Exact 
mass  
Nominal 
Mass 
Mass 
defectb 
Ambuic acid 
(C19H26O6) 
 
 
349.1651a 349 0.1651 
 
Ambuic acid + 
oxygen 
(C19H26O7) 
  
365.1600a 365 0.1600 
Oxygen  15.9949 16 -0.0051 
a Represent negatively charged ions, [M-H]- in the mass spectrometer 
b Exact mass- nominal mass = mass defect 
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networks for analysis. Before the networks are formed, connections between nodes are 
created computationally within the GNPS platform by converting the MS/MS spectra into 
vectors and comparing their similarities (B). The vector units undergo a pair-wise dot 
product calculation to calculate the cosine similarity score where higher values 
(maximum of 1) represent similar fragmentation patterns(C).52 Cosine similarity scores 
are used to plot the final molecular networks (D), in which each circular node in the final 
molecular network represents an m/z value of an ion detected in the full MS 
chromatogram.  A network is a group of nodes, which represent ions tat fragment 
similarly.		
	
 
Figure 3. A Simplified Visual Representation of Global Natural Product Social Molecular 
Networking (GNPS).41 (A) Full MS spectra are acquired.  (B) MS/MS data are utilized to 
identify clusters of m/z values that correspond to structurally related compounds. (C) 
Connectivity or relativeness of the nodes is calculated computationally and (D) the results 
are visually represented by a molecular network. The circular nodes connected in a final 
molecular network are representative of ions detected for which MS/MS spectra were 
similar based on computed similarity scores. 
 
 
Molecular networks were produced using MS/MS data from the P. microspora 
organic extract (Figure 2). One molecular network contained accurate masses 
corresponding to ambuic acid and several associated adducts (ambuic acid dimer, formic 
A B
 
C
 
D
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acid adduct, and chlorine adduct) along with putative ambuic acid analogues (Figure 4). 
The cluster of interest contained 17 ions that were above the cosine similarity scoring of 
0.7 and shared at least 5 MS/MS fragments with ambuic acid. In this molecular network, 
green nodes represent m/z values specific to ambuic acid, red nodes represent m/z values 
that were found using both mass defect filtering and molecular networking, and the blue 
nodes were only found using molecular networking. Notably, molecular networking 
identified a much smaller set of ions related to ambuic acid than was obtained with mass 
defect filtering. While mass defect filtering identified a subset of 84 putative analogues of 
ambuic acid, the molecular network is comprised of only 17 ions.  
 
  
Figure 4. Molecular Network Containing Ambuic Acid and Putative Structural 
Analogues. The network is composed of the ions that have similar MS/MS fragmentation 
pattern to ambuic acid and adducts of ions are labeled with appropriate ion description: 
[M-H]- (deprotonated molecular ion), [M-H+FA]- (formic acid adduct), [2M-H]- (proton 
bound dimer of two deprotonated molecular ions), and [M+Cl]- (chloride adduct). The 
green nodes represent ambuic acid and mass spectral adducts. The red nodes represent 
16 
ions that were identified as potential ambuic acid analogues by both mass defect filtering 
and molecular networking, and blue nodes were identified as potential analogues only by 
molecular networking. 
 
 
2.3.4. Comparison of Molecular Networking and Mass Defect Filtering Analysis of 
P. microspora Data 
All priority peaks were compiled into one master list, shown in Table 2. Each ion 
was manually examined in the. RAW (Thermo) file on XCalibur and noted if there was 
fragmentation of this ion not. Each ion is annotated with a footnote on discovery method. 
(MN=molecular networking; MDF=mass defect filtering; a=MDF only, no 
fragmentation; b=MDF only, fragmentation patterns do not match; c= in both, MDF and 
MN; d=MN only, below baseline; e=MN only, outside MDF window) There were five 
main ion categories that were created and more discussion is available in Figure 5. The 
ion number were also utilized in Table 3, when the large peak list was further filtered to 
identify peaks that were found to be related to ambuic acid.  
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Table 2. Mass Defect Filtered and Molecular Networking Peak List. The. RAW (Thermo) 
data is converted to mzML format and imported onto GNPS for molecular networking. 
The resulting cluster analysis is searched for the node represented for ambuic acid m/z 
ions. All ions for with the m/z falls within ±50 Da window of ambuic acid ions (2M-H]-, 
[M+FA-H]-, [M-H]-) are included. [M-H]-, [M+FA-H]-, [2M-H]-, and [M+Cl-H]- 
represent negatively charged ions produced by mass spectrometer in negative ion mode 
and mean the precursor exact mass minus a proton, precursor exact mass with a formic 
acid (FA) adduct minus a proton, double the precursor exact mass minus a proton, and 
precursor exact mass with chlorine (Cl) adduct minus a proton, respectively. 
 
Ion number m/z value Retention time Fragmented? Discovery 
method 
1 223.1335 4.64 N a 
2 250.1205 4.64 N a 
3 257.1543 4.64 N a 
4 265.1475 8.52 N a 
5 265.1476 5.46 N a 
6 265.1476 8.05 N a 
7 266.1155 3.38 N a 
8 266.1508 5.46 N a 
9 267.1419 5.46 N a 
10 287.1647 4.64 N a 
11 293.1790 6.42 Y b 
12 297.1527 5.4 Y b 
13 298.1559 5.48 Y b 
14 307.1947 6.98 Y b 
15 311.1683 8.47 Y b 
16 311.1685 8.05 Y b 
17 311.1685 6.01 Y b 
18 312.1716 6.01 N a 
19 319.1546 4.64 N a 
20 325.1839 8.52 Y b 
21 325.1840 6.36 Y b 
22 325.1841 8.05 Y b 
23 326.1872 6.36 N a 
24 327.1404 0.46 Y b 
25 328.1241 0.46 N a 
26 331.1547 4.64 N a 
27 339.1996 6.83 Y b 
28 347.1500 4.33 Y d 
29 349.1651 4.64 Y c 
30 349.1655 4.12 Y b 
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31 350.1685 4.64 N a 
32 351.1808 3.79 Y b 
33 351.1810 3.55 Y b 
34 351.1810 4.77 Y d 
35 352.1842 3.79 N a 
36 355.1578 8.47 Y b 
37 365.1240 3.51 Y d 
38 365.1600 2.97 Y c 
39 365.1602 3.36 Y c 
40 366.1633 3.38 N a 
41 366.1634 2.92 N a 
42 367.1758 3.44 Y b 
43 369.1550 3.91 Y d 
44 377.1965 6.33 N a 
45 377.1966 6.12 N a 
46 379.1579 8.05 N a 
47 381.1735 8.52 Y b 
48 382.1758 8.52 N a 
49 383.1710 3.11 Y b 
50 385.1420 4.61 Y d 
51 385.1422 4.64 Y c 
52 387.1577 3.79 N a 
53 388.1176 0.43 N a 
54 391.1761 4.26 Y b 
55 393.1555 4.48 Y c 
56 393.1918 4.07 N a 
57 394.1949 4.07 N a 
58 395.1707 4.23 Y b 
59 395.1708 4.64 Y c 
60 396.1738 4.64 N a 
61 397.1500 3.41 Y b 
62 397.1758 4.64 N a 
63 397.1863 3.55 N a 
64 397.1864 4.78 N a 
65 397.1864 3.79 N a 
66 397.2490 4.24 Y e 
67 398.1895 3.79 N a 
68 398.1897 3.55 N a 
69 398.1898 4.78 N a 
70 399.1915 3.79 N a 
71 409.1500 3.02 Y d 
19 
72 411.1657 2.97 Y c 
73 411.1657 3.36 Y c 
74 411.1659 3.22 Y b 
75 411.1659 3.9 Y b 
76 411.1659 4.42 Y b 
77 411.2019 3.77 N a 
78 412.1607 4.64 Y b 
79 412.1690 3.38 N a 
80 412.1690 2.92 N a 
81 413.1815 3.74 N a 
82 413.1815 3.33 N a 
83 414.1764 3.79 Y b 
84 417.1524 4.61 N a 
85 419.1682 3.82 N a 
86 427.1604 3.44 Y b 
87 427.1604 3.52 Y b 
88 429.1764 3.11 Y b 
89 433.1472 3.38 N a 
90 463.1579 4.64 N a 
91 465.1737 3.79 N a 
92 695.3090 4.38 Y e 
93 699.3380 4.61 Y e 
94 731.3280 3.36 Y e 
MN=molecular networking; MDF=mass defect filtering; a=MDF only, no 
fragmentation; b=MDF only, fragmentation patterns do not match; c= in both, MDF 
and MN; d=MN only, below baseline; e=MN only, outside MDF window 
 
 
 Having multiple data mining methods to examine data and prioritize sample 
components is helpful to ensure a complete interpretation of the dataset. A combined list 
of possible ambuic acid analogues (94 prioritized ions) identified by mass defect filtering 
and molecular networking are provided in Table S1. Some ions were only identified by 
one data analysis approach, while others were identified by both methods. Figure 5 is a 
visual depiction of the distribution of the 94 compiled prioritized peaks. A total of 183 
ions were detected above the baseline of 3 × 106 in the negative ion mode, 84 of which 
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had a mass defect within 50 mDa of that of ambuic acid. This is a lengthy list, 
representing nearly half of all ions detected, and isolation of all these ions to confirm 
their identity would not be possible given constraints of time and sample quantity.  Thus, 
we sought to further narrow the list of putative analogues by employing molecular 
networking.  
 Out of the 84 ions prioritized by mass defect filtering, 46 ions (orange) were not 
fragmented using the data-dependent LC-MS/MS method.  This could occur due to their 
low abundance or because of co-elution with more abundant ions. There were 30 ions 
from among those prioritized with mass defect filtering (green) that had fragmentation 
patterns that did not match ambuic acid. These ions were likely falsely identified as 
ambuic acid analogues by mass defect filtering, illustrating that compounds with similar 
mass defect do not necessarily share structural relatedness. There were 8 ions (blue) that 
fell within the mass defect window of interest and shared similar fragmentation patterns 
with ambuic acid. An additional 10 ions were identified only by molecular networking, 6 
of which (red) were not identified by mass defect filtering because they were detected 
below the baseline used for peak picking (3 × 106), and 4 ions (purple) fell above the 
mass defect window of ±50 mDa. Notably, these 3 of the 4 ions outside the mass defect 
range represent dimers [2M-H]- of analogues, and one represented an unknown. When 
looking at the data via the mass defect filtering, these ions would be considered a false 
negative, because they were not included in the priority list. However even though they 
were outside the range of the mass defect window, when looking back at the .RAW data 
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the discovery of the dimers would be apparent. A [2M-H]- dimer is commonly seen in 
mass spectrometry59 and the peak list would contain the precursor ion. Having dimers in 
the peak list would be a secondary ion for one component. The fourth ion in this category 
was an unknown and was a false positive that would not have been discovered without 
the secondary data mining technique. The fragmentation fingerprint was examined to 
determine structural similarity along with other examples of ions in each of the 
categories. 
 Having this comparison illustrates that while there is some overlap between mass 
defect filtering and molecular networking (8 ions), the ions identified as putative 
analogues are largely different using the two different approaches. Mass defect filtering 
provided a much larger list, containing many putative false positives (30 out of 84). 
Molecular networking has prioritized a much smaller subset of ions but could risk false 
negative results by only looking at ions with MS/MS spectra. Over half of the ions 
identified by mass defect filtering were not fragmented using the data-dependent LC-MS 
method and cannot be confirmed or rejected as putative analogues.  
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Figure 5. Comparison and Categorization of Ions Detected with Mass Defect Filtering 
(MDF) and Molecular Networking (MN).  After mass defect filtering, 84 ions were 
prioritized, 46 (orange) were not fragmented and the structural relatedness could not be 
determined, 30 (green) had fragmentation but did not match the target analyte, and 8 ions 
(blue) overlapped with those identified using molecular networking. There were 10 
additional ions identified by molecular networking alone, in which 6 (red) were below the 
threshold baseline set in the mass defect filtering and 4 (purple) were outside the mass 
defect window of 50 mDa from ambuic acid. 3 out of the 4 (purple) were due to dimers, 
and one was and unknown that has a fragmentation pattern that is similar to ambuic acid. 
 
 
Fragmentation patterns of selected ions identified as putative ambuic acid 
analogues by one or both are illustrated in Figure 6. Fragmentation spectra of the analyte 
of interest, ambuic acid, are depicted in Figure 6A (the most abundant precursor ion of 
ambuic acid is the formic acid adduct [M+FA-H]-, m/z 395.1708) and fragments that 
were found in the spectra for putative analogues have been highlighted and annotated 
with corresponding m/z values. In Figure 6B, the fragmentation spectrum of a putative 
analogue identified by both mass defect filtering and molecular networking are shown. 
This compound (m/z 365.1602) shares many fragments with ambuic acid and is likely  
structurally related. In Figure 6C, fragmentation spectrum of an analogue only identified  
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with molecular networking and was a false-negative for mass defect filtering is shown 
(m/z 731.3280). Notably, the fragmentation spectra still show a high degree of overlap 
with the spectra of ambuic acid (Figure 6A), even though the mass defect (0.3380) falls 
outside of the 50 mDa range used for mass defect filtering. Thus, the ion at m/z 731.3280 
is likely a relative of ambuic acid that would have been overlooked using just mass defect 
filtering. The example in Figure 6D is an ion (m/z 397.2228) that was only found by 
molecular networking and was outside of the mass defect range. This was the only ion in 
this category that was not a dimer and is a true false negative. This ion would have not 
been seen through data processing if mass defect filtering was the only mining technique.  
Finally, Figure 6E illustrates the fragmentation spectrum of a compound identified only 
by mass defect filtering (m/z 391.1761) and is a representative example of a false-positive 
of mass defect filtering. Although this compound falls within the mass defect range of 
ambuic acid, the fragmentation pattern does not overlap with that of ambuic acid, 
suggesting that it is not structurally related to this compound and that it was falsely 
identified as an analogue using mass defect filtering. 
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Figure 6. Comparison of the Fragmentation (MS/MS) Spectra of the Putative Ambuic 
Acid Analogues. For ease of comparison, the main fragments that match in multiple 
spectra are color coded and labeled with fragment m/z value in each spectrum (A-E) if 
present. (A) Ambuic acid with formic acid adduct in negative mode, [M-H+FA]- (m/z 
395.1758), fragmentation pattern. (B) One of the putative analogues discovered by mass 
defect filtering and molecular networking (m/z 365.1600) with highlighted fragments. (C) 
One of the dimers found only in molecular networking because it was outside of the mass 
defect range (m/z 731.3280) with highlighted fragments. (D) One of the putative 
analogues found only in molecular networking (m/z 397.2228), which has over five 
fragments required to be clustered with ambuic acid in the molecular network. (E) One of 
the putative analogues found with mass defect filtering (m/z 391.1761), which does not 
share any fragments with spectrum obtained for ambuic acid. 
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B 
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The way in which the mass defect window is defined directly affects the number 
of ions that will be identified as putative analogues. A narrower window will result in 
fewer ions being identified as potential analogues and will minimize the chance of false 
positives. However, a narrower window will also result in an increase in the number of 
false negatives. To demonstrate this concept, a comparison of the distribution of ions 
from the P. microspora extract falling in various mass defect ranges is shown in Figure 7. 
While a total of 84 ions are identified within the mass defect window of 50 mDa (blue 
bars), only 61 are identified in the 20 mDa mass range.  The number of ions tentatively 
identified as ambuic acid analogues with molecular networking in each given mass 
window are also shown. The data for analogues identified with molecular networking 
(orange bars) demonstrates that each time the mass window is narrowed, a greater 
number of potential analogues is missed due to relevant ions falling outside the chosen 
window.  3 of the 4 ions in orange in the above 50 mDa category are dimers, the last ion 
is a putative analogue of ambuic acid and would have been missed. Having the widest 
window possible would give you the full peak list, the concept of data mining is to filter 
or funnel the data to prioritize the ions that are indeed related to the desired precursor ion. 
The user has the ability to define the window in a way that would best benefit the project 
and would have to be optimized for the goals attempting to achieve. 
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Figure 7. A Comparison of the Distribution of the 94 Prioritized Ions’ Mass Defect 
Deviation(mDa) from Ambuic Acid. The number of ions identified in the given mass 
defect range using mass defect filtering (MDF, blue) and molecular networking (MN, 
orange) are shown. The ions in orange have been confirmed by MS/MS data as ions that 
are identified to be related to ambuic acid. Some ions are repetitious for ions that were 
more abundant, 3 of the 4 ions in the above 50mDa range is due to dimerization within 
the mass spectrometer. 
 
 
Figure 5 had shown the overlap of discovery with both techniques as well as the 
false-negatives mass defect filtering had left out. 17 ions have been described from the 
molecular network and have been manually examined to ensure the relatedness, some 
ions are repetitious for the same component. This same network (Figure 4) has been 
recolored nodes to visualize the eight unknowns and ambuic acid in Figure 8. The purple 
nodes are the m/z values of Unknown A, green for ambuic acid, red for Unknown B, pink 
for Unknown C, aqua for Unknown D, yellow for Unknown E, dark blue for Unknown F, 
35
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and light green for Unknown G. Unknown D and E are isomers of each other. The nodes 
have also been labelled with the type of ion and Table 3 summarizes the network. 
 
 
Figure 8. Molecular Network Color-coded into Different Compound Assignments. The 
network is composed of the ions that have similar MS/MS fragmentation patterns.  The 
adducts of ions are labeled with appropriate description: [M-H]-, [M-H+FA]-, [2M-H]-, 
and [M+Cl]-, where FA represents formic acid and Cl represents chlorine.  The network 
has identified 8 different compounds within the extract, 1 accounts for ambuic acid and 
the other 7 other unknowns. The purple nodes are the m/z values of Unknown A, green 
for ambuic acid, red for Unknown B, pink for Unknown C, aqua for Unknown D, yellow 
for Unknown E, dark blue for Unknown F, and light green for Unknown G. Unknown D 
and E are isomers of each other. 
 
 
The has been also transformed into Table 3 with the putative molecular formula. 
This list is much more manageable for isolation efforts verses the 183 isolatable ions first 
prioritized. Having the MS/MS data of the ions allows us to make predictions of the 
putative molecular formula. Confirmation of this would have to be confirmed via 
[M-H]- [M-H]- [M-H]- 
[M-H]- 
[M-H]- 
[M-H]- 
[M-H]- 
[M-H+FA]- [M-H+FA]- [M-H+FA]- 
[M-H+FA]- 
[M-H]- 
[2M-H]- [2M-H]- 
[2M-H]- 
[M+Cl]- 
[M-H+FA]- 
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structure elucidation and was out of the scope of this data mining comparison. Table 3 
also contains the ion number assigned in original combined peak list for both molecular 
networking and mass defect filtering in Table 2. 
 
Table 3. Predicted Analogue Identification. The 17 ions visualized by the molecular 
network are annotated to assessed within the original data file to confirm there were 7 
unknowns compounds that have been prioritized with both molecular networking and 
mass defect filtering to be related to the target analyte, ambuic acid. Unknown D and E 
are isomers of each other. 
 
Compound Proposed 
chemical 
formula 
m/z value Ion Type Ion 
number 
(Table S1) 
Molecular 
Network node 
color 
Unknown A C21H29O7 347.1500 [M-H]- 28  
393.1555 [M-H+FA]- 55 
695.3080 [2M-H]- 92 
Ambuic 
Acid 
C19H26O6 349.1651 [M-H]- 29  
385.1422 [M+Cl]- 51 
395.1708 [M-H+FA]- 59 
699.3383 [2M-H]- 93 
Unknown B C19H27O6 351.1810 [M-H]- 34  
Unknown C C18H21O8 365.1240 [M-H]- 37  
Unknown D C19H26O7 365.1600 [M-H]- 38  
411.1657 [M-H+FA]- 72 
Unknown E C19H26O7 365.1602 [M-H]- 39  
411.1657 [M-H+FA]- 73 
731.3280 [2M-H]- 94 
Unknown F C18H25O8 369.1550 [M-H]- 43  
Unknown G C18H21O8 409.1500 [M-H]- 71  
Unknown H C21H33O7 397.2240 [M-H]- 66  
 
 
All of the 94 prioritized peaks (Table 2) were individually examined for 
fragmentation data and the final prioritized eight unknowns and ambuic acid first 
discussed in the molecular network (Figure 8) and the ions have been further described to 
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connect all of the results from both data mining processes into Table 3. In Figures 9-17 
the extracted ion chromatogram of each are each of the related unknowns (Unknown A-
H) and ambuic in section A. within section B of Figures 9-17 the fragmentation 
fingerprint is displayed. On each of the spectra there are the highlighted ions that were 
detected by molecular network. Majority of the extracted ion chromatograms have 
multiple peaks throughout the chromatogram and were individually examined to 
determine whether they are in fact not related to ambuic acid by MS/MS comparison. The 
retention time is labelled within section a to signify the ion that has been prioritized. It is 
notable to again reference the discovery of structurally related isomer seen in Figure 13 
and 14 for Unknown D and E respectively. To complete the assessment of the analogues, 
they would have to be individually isolated and subjugated to structure elucidation. 
 
 
Figure 9. Unknown A Mass Spectral Data. (A) Extracted Ion Chromatogram (XIC) for 
Unknown A eluting at 4.48 min. (B) MS/MS fragmentation fingerprint. Highlighted are 
the ions that were found in the molecular network m/z values of 347.1500, 393.1555, 
695.3080 representing [M-H]-, [M-H+FA]-, [2M-H]- respectively. 
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Figure 10. Ambuic Acid Mass Spectral Data. (A) Extracted Ion Chromatogram (XIC) for 
ambuic acid eluting at 4.64 min. (B) MS/MS fragmentation fingerprint. Highlighted are 
the ions that were found in the molecular network m/z values of 349.1650, 385.1421, 
395.1704, 699.3376 representing [M-H]-, [M+Cl]-, [M-H+FA]-, [2M-H]- respectively. 
 
 
 
Figure 11. Unknown B Mass Spectral Data. (A) Extracted Ion Chromatogram (XIC) for 
ambuic acid eluting at 4.78 min. (B) MS/MS fragmentation fingerprint. Highlighted are 
the ions that were found in the molecular network m/z values of 351.1811 representing 
[M-H]-. 
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Figure 12. Unknown C Mass Spectral Data. (A) Extracted Ion Chromatogram (XIC) for 
ambuic acid eluting at 3.60 min. (B) MS/MS fragmentation fingerprint. Highlighted are 
the ions that were found in the molecular network m/z values of 365.1239 representing 
[M-H]-. 
 
 
 
Figure 13. Unknown D Mass Spectral Data. (A) Extracted Ion Chromatogram (XIC) for 
ambuic acid eluting at 2.97 min. (B) MS/MS fragmentation fingerprint. Highlighted are 
the ions that were found in the molecular network m/z values of 365.1600 and 411.1657 
representing [M-H]- and [M-H+FA]- respectively. 
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Figure 14. Unknown E Mass Spectral Data. (A) Extracted Ion Chromatogram (XIC) for 
Unknown A eluting at 3.36 min. (B) MS/MS fragmentation fingerprint. Highlighted are 
the ions that were found in the molecular network m/z values of 365.1600, 411.1657, 
731.3280 representing [M-H]-, [M-H+FA]-, [2M-H]- respectively. 
 
 
 
Figure 15. Unknown F Mass Spectral Data. (A) Extracted Ion Chromatogram (XIC) for 
ambuic acid eluting at	3.91 min. (B) MS/MS fragmentation fingerprint. Highlighted are 
the ions that were found in the molecular network m/z values of 369.1551 representing 
[M-H]-. 
150 200 250 300 350 400 450 500 550 600 650 700 750
m/z
0 1 2 3 4 5 6 7 8 9 10
Time (min)
0
20
40
60
80
100
R
el
at
iv
e
Ab
un
da
nc
e
3.36
365.1600
0
20
40
60
80
100
R
el
at
iv
e
Ab
un
da
nc
e
365.1600
411.1657
100
731.3280
0 1 2 3 4 5 6 7 8 9 10
Time (min)
0
20
40
60
80
100
R
el
at
iv
e
Ab
un
da
nc
e
369.1551
369.1551
0
20
40
60
80
100
R
el
at
iv
e
Ab
un
da
nc
e
150 200 250 300 350 400 450 500 550 600 650 700 750
m/z
100 800
3.91 
A 
B 
A 
B 
33 
 
Figure 16. Unknown G Mass Spectral Data. (A) Extracted Ion Chromatogram (XIC) for 
ambuic acid eluting at	3.88 min. (B) MS/MS fragmentation fingerprint. Highlighted are 
the ions that were found in the molecular network m/z values of 409.1502 representing 
[M-H]-. 
 
 
	
	
	
	
	
		 
 
 
Figure 17. Unknown H Mass Spectral Data. (A) Extracted Ion Chromatogram (XIC) for 
ambuic acid eluting at 4.24 min. (B) MS/MS fragmentation fingerprint. Highlighted are 
the ions that were found in the molecular network m/z values of 397.2228 representing 
[M-H]-. (C) A zoom in to 397.2228, which was one of the minor eluting peaks at that 
time point. 
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2.4 Discussion  
 
As this study demonstrates, mass defect filtering and molecular networking can be 
utilized to identify compounds that are likely to be analogues of a molecule of interest. 
With this project, we aimed to compare techniques (mass defect filtering and molecular 
networking) to answer the same question: does the complex extract prepared from 
Pestalotiopsis microspora contain analogues of ambuic acid? Interestingly, some putative 
analogues were only identified with one methodology, while others were identified with 
both approaches. The comparison of these approaches has allowed us to identify the 
strengths and weaknesses of each approach.  
Mass defect filtering is a simple technique to narrow down full peak lists for 
peaks of interest using only full MS data. Because mass is an intrinsic property of 
molecules, it does not change from one analysis to the next. As such, the mass defect, 
extracted from the finite exact mass of a desired precursor ion, can be used to interpret 
the elemental components of a molecule, as well as to identify other compounds within a 
complex mixture with similar elemental composition. The simplicity of this method 
offers an advantage for laboratories with limited access to MS/MS capable 
instrumentation, where mass defect filtering can serve as an excellent starting point to 
assess whether putative analogues of a desired compound of interest exist within a given 
sample. The subsequent peak list can be used to build a list of ions to prioritize for follow 
up studies. By including the generation of MS/MS spectra of prioritized ions, enabling 
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direct comparison of fragmentation patterns to determine which of the ions are, in fact, 
related. 
Despite its accessibility and simplicity, the mass defect filtering approach is more 
prone to false positives than is molecular networking. Without MS/MS fragmentation 
patterns, it is challenging to confirm whether each result from the mass defect filtering is 
structurally related. When applied to the simplified P. microspora case, mass defect 
filtering identified a subset of 84 masses for prioritization for the one extract.  Clearly, 
the isolation of 84 ions to confirm structure is not feasible.  However, it would be 
possible to manually examine the MS/MS spectra to determine which among them are 
likely to be ambuic acid analogues as a way to prioritize compounds for isolation.  The 
molecular networking dataset yielded only 17 ions, which is a more tractable list for 
follow up isolation studies. Out of the 84 ions that were prioritized in this simplified 
example (representing nearly half of all ions detected above baseline), nearly 35% did not 
possess similar fragmentation spectra to ambuic acid (Figure 6). An additional 46 ions 
were not fragmented using the LC-MS method, and it was not possible to confirm 
whether these are related to ambuic acid. These ions may have had a low signal intensity 
compared to other ions detected at each scan or may have co-eluted and undergone ion 
suppression with multiple high abundant analytes, and as such may not have been 
fragmented with the data-dependent method utilized for this study.  
Molecular networking has advantages with untargeted analysis as well as the 
targeted identification of known compounds. This approach has the ability to add 
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annotations from multiple small molecule databases by matching MS/MS spectra within 
the user’s data to other spectra uploaded on the website.  
The molecular network clusters together nodes using user-defined parameters. 
Molecular networking, unlike mass defect filtering, involves numerous steps and data 
transformations and could be prone to misinterpretation if parameters are not optimized. 
However, when optimized parameters are used, the approach can be highly effective for 
identifying analogues of the molecule of interest. There are some notable disadvantages 
of molecular networking.  The molecular networking approach is far more complicated as  
a method of data analysis, and it only identifies analogues for which MS/MS data are 
generated. If an extract component is not detected at sufficient abundance to generate an 
MS/MS spectrum, it will not be detected with molecular networking. Using the mass 
defect information of the 46 ions that were not fragmented, for complete coverage of the 
metabolome adding this to an inclusion list when acquiring mass spectrometry data can 
confirm whether there is relatedness.  
Finally, it is worth noting that several possible analogues were only detected with 
either mass defect filtering or molecular networking (Figure 5), thus, to achieve the most 
comprehensive data mining interpretation, it would be useful to employ both techniques.  
A molecular network has been color-coded into compound assignment (Figure 8), the 
consolidation of data and predicted analogue identification in Table 3, and the confirming 
MS/MS spectra for ambuic acid and the eight unknowns and their associated adducts in 
Figure 9-18. 
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2.5 Conclusion 
The range of metabolites produced by fungal organisms such as P. microspora is 
vast, and analysis of such complex mixtures by LC-MS can yield enormous datasets. The 
results of this study illustrate that post-acquisition filtering of these datasets, including 
mass defect filtering and molecular networking, can facilitate target identification by 
removing signals that are not related to the metabolite of interest. Mass defect filtering 
and molecular networking represent complementary approaches to answer the same  
question and can be used in tandem to group structurally related compounds in complex 
natural product mixtures. Ultimately, these approaches both have unique benefits and 
utilization of both approaches represents a promising strategy for natural product lead 
prioritization.  
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